Udvalget for Humanmedicinske Lægemidler (CHMP) fandt, at det i overensstemmelse med EU - kravene har vist sig, at Valtropin har en kvalitets -, sikkerheds - og effektprofil, der er sammenlignelig med Humatropes.
The Committee for Medicinal Products for Human Use (CHMP) considered that, in accordance with European Union requirements, Valtropin has been shown to have a comparable quality, safety and efficacy profile to Humatrope.